0.10 (-20.32%)
As of Mar 22, 2023
Source:
Obseva Sa is a biopharmaceutical company focused on the development of novel therapies to improve women’s reproductive health. We are advancing a development program for nolasiban, an oral oxytocin receptor agonist, focused on improving clinical pregnancy and live birth rates in women undergoing in-vitro fertilization.
Country | United States |
Headquarters | plan-les-ouates |
Phone Number | 0041-0-22-552-1558 |
Industry | manufacturing |
CEO | Will Brown |
Website | obseva.com |